Encompass Health EPS - Earnings per Share 2012-2026 | EHC
Encompass Health annual and quarterly earnings per share history from 2012 to 2026. Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
- Encompass Health EPS for the quarter ending June 30, 2026 was $1.54, a 10.79% increase year-over-year.
- Encompass Health EPS for the twelve months ending June 30, 2026 was $6.14, a 20.16% increase year-over-year.
- Encompass Health 2025 annual EPS was $5.54, a 24.22% increase from 2024.
- Encompass Health 2024 annual EPS was $4.46, a 28.53% increase from 2023.
- Encompass Health 2023 annual EPS was $3.47, a 28.52% increase from 2022.
| Encompass Health Annual EPS | |
|---|---|
| 2025 | $5.54 |
| 2024 | $4.46 |
| 2023 | $3.47 |
| 2022 | $2.70 |
| 2021 | $4.11 |
| 2020 | $2.85 |
| 2019 | $3.61 |
| 2018 | $2.93 |
| 2017 | $2.84 |
| 2016 | $2.59 |
| 2015 | $1.91 |
| 2014 | $2.29 |
| 2013 | $2.58 |
| 2012 | $1.67 |
| 2011 | $1.91 |
| Encompass Health Quarterly EPS | |
|---|---|
| 2026-06-30 | $1.54 |
| 2026-03-31 | $1.93 |
| 2025-12-31 | $1.43 |
| 2025-09-30 | $1.24 |
| 2025-06-30 | $1.39 |
| 2025-03-31 | $1.48 |
| 2024-12-31 | $1.18 |
| 2024-09-30 | $1.06 |
| 2024-06-30 | $1.12 |
| 2024-03-31 | $1.10 |
| 2023-12-31 | $0.86 |
| 2023-09-30 | $0.84 |
| 2023-06-30 | $0.90 |
| 2023-03-31 | $0.87 |
| 2022-12-31 | $0.89 |
| 2022-09-30 | $0.45 |
| 2022-06-30 | $0.49 |
| 2022-03-31 | $0.87 |
| 2021-12-31 | $0.91 |
| 2021-09-30 | $1.00 |
| 2021-06-30 | $1.13 |
| 2021-03-31 | $1.07 |
| 2020-12-31 | $0.86 |
| 2020-09-30 | $0.78 |
| 2020-06-30 | $0.34 |
| 2020-03-31 | $0.87 |
| 2019-12-31 | $0.68 |
| 2019-09-30 | $0.98 |
| 2019-06-30 | $0.92 |
| 2019-03-31 | $1.03 |
| 2018-12-31 | $0.28 |
| 2018-09-30 | $0.89 |
| 2018-06-30 | $0.92 |
| 2018-03-31 | $0.84 |
| 2017-12-31 | $0.77 |
| 2017-09-30 | $0.67 |
| 2017-06-30 | $0.70 |
| 2017-03-31 | $0.70 |
| 2016-12-31 | $0.69 |
| 2016-09-30 | $0.64 |
| 2016-06-30 | $0.65 |
| 2016-03-31 | $0.61 |
| 2015-12-31 | $0.50 |
| 2015-09-30 | $0.52 |
| 2015-06-30 | $0.45 |
| 2015-03-31 | $0.44 |
| 2014-12-31 | $0.44 |
| 2014-09-30 | $0.52 |
| 2014-06-30 | $0.85 |
| 2014-03-31 | $0.48 |
| 2013-12-31 | $-0.14 |
| 2013-09-30 | $0.58 |
| 2013-06-30 | $1.66 |
| 2013-03-31 | $0.48 |
| 2012-12-31 | $0.42 |
| 2012-09-30 | $0.43 |
| 2012-06-30 | $0.43 |
| 2012-03-31 | $0.39 |
| 2011-12-31 | $0.47 |
| 2011-09-30 | $0.54 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $12.036B | $5.935B |
| Encompass Health Corporation is a provider of integrated healthcare services. It offers both facility-based and home-based patient care through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The company delivers high-quality, cost-effective, integrated care in the healthcare space. It provides a continuum of facility-based and home-based post-acute services for its patients and their families, which will gain more prevalence as coordinated care and integrated delivery payment models, such as accountable care organizations and bundled payment arrangements. The company operates through two segments: Inpatient Rehabilitation as well as Home Health and Hospice business. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $29.581B | 13.26 |
| Quest Diagnostics (DGX) | United States | $27.271B | 23.22 |
| DaVita (DVA) | United States | $12.179B | 14.91 |
| Elanco Animal Health (ELAN) | United States | $11.491B | 21.70 |
| Chemed (CHE) | United States | $6.620B | 23.60 |
| RadNet (RDNT) | United States | $6.069B | 175.27 |
| LifeStance Health (LFST) | United States | $4.991B | 100.46 |
| Option Care Health (OPCH) | United States | $3.523B | 14.89 |
| Aveanna Healthcare Holdings (AVAH) | United States | $3.123B | 21.68 |
| Addus HomeCare (ADUS) | United States | $2.164B | 19.57 |
| Astrana Health (ASTH) | United States | $2.138B | 22.69 |
| Pennant (PNTG) | United States | $1.396B | 36.34 |
| U.S Physical Therapy (USPH) | United States | $1.220B | 32.19 |
| Daxor (DXR) | United States | $0.065B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.024B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |